PUMCH among 1st batch of demonstration centers for rheumatism-related PAH
CopyFrom: PUMCH UpdateTime: 2016-06-07 Hits: 95 Font Size: SmallBig

On November 27, 2015, a plate-granting ceremony was held in Beijing, at which PUMCH stood out from nearly 80 applicants to become one of the seven first-batch national demonstration centers for standardized treatment of rheumatism-related PAH and experience exchange.

The project, initiated by the Chinese SLE Treatment and Research Group (CSTAR) and the Chinese Rheumatism Data Center (CRDC), aims at further standardizing the diagnosis and treatment of CTD-related pulmonary arterial hypertension (PAH), and improving the prognosis of severe rheumatism patients of this kind. CSTAR and CRDC carefully analyzed each applicant’s information on the time and number of treatment, personnel, multidisciplinary efforts and potential for clinical and research work, and finally selected seven of them to be China’s first-batch demonstration centers, into which our hospital was included.